Emily E.F. Fekete

SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition

Taha Azad, Ragunath Singaravelu, Emily E.F. Fekete et al. · Biosensors and Bioelectronics · 2021 · 32 citations · Full text

Engineering, Biotechnology, Molecular Biology +14

Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry

Taha Azad, Ragunath Singaravelu, Zaid Taha et al. · Molecular Therapy · 2021 · 26 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection

Stephen Boulton, Joanna Poutou, Nikolas T. Martin et al. · Molecular Therapy · 2021 · 23 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

An economic and robust TMT labeling approach for high throughput proteomic and metaproteomic analysis

Marybeth Creskey, Leyuan Li, Zhibin Ning et al. · PROTEOMICS · 2022 · 23 citations · Full text

Life Sciences, Biochemistry, Biotechnology +15

CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX

Jack T. Whelan, Ragunath Singaravelu, Fuan Wang et al. · Frontiers in Immunology · 2023 · 13 citations · Full text

Life Sciences, Biotechnology, Immunology +17